The antibody-based pharmaceuticals resource library’s Podcast

Latest Episodes:

How To Make Transiently Redirected T Cells Nov 03, 2022

Show notes

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.

Chance and Challenge in Tumor Immunotherapy Nov 03, 2022

Show notes

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.

What Are the Related Technologies of T Cell Gene Transfer Nov 02, 2022

Show notes

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.

T Cell-Based Immunotherapy for Tumor Oct 30, 2022

Show notes

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.

Webinar: A Potent SARS-CoV-2 Neutralizing Single-domain Antibody (SdAb) Shows Therapeutic Efficacy in the Syrian Golden Hamster Model of COVID-19 Oct 27, 2022

Show notes

Creative Biolabs has invited Dr. James Naismith to walk us through the development process of his novel SARS-CoV-2 neutralising sdAbs and how his team has found a candidate demonstrating promising therapeutic efficacy in a hamster model of COVID-19.

Oligonucleotide-based Therapeutics Oct 21, 2022

Show notes

Oligonucleotides are nucleic acid polymers with potential to treat or manage a wide range of diseases. Oligonucleotide-based therapeutics employ chemically synthesized oligonucleotides with single-stranded DNA or RNA backbone of specific potential. Here, we will discuss the different types of oligonucleotide-based therapies, and some featured solutions provided by Creative Biolabs.

Webinar-Development of Gene Therapy for Genetic Hearing Loss Oct 21, 2022

Show notes

Creative Biolabs has invited Dr. Jeffrey R. Holt to walk us through how gene therapy has become a promising treatment for genetic hearing loss and how his team developed unique gene therapy strategies for genetic hearing loss.

Webinar-Optimal Therapeutic Intervention Timepoints for siRNA-Based Huntington’s Disease Therapies Oct 21, 2022

Show notes

Creative Biolabs has invited Dr. Markita Landry to walk us through how her team developed a near Infrared Catecholamine nanosensor (nIRCat) and used real-time imaging to find out what drives late-disease decreases in evoked dopamine release, and how to use these findings as optimal therapeutic intervention timepoints for siRNA-based Huntington's disease therapies.

The Injection Time and Dosage of the Dendritic Cell Vaccine Oct 19, 2022

Show notes

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.

The Route of Administration of Messenger RNA Loaded Dendritic Cells Oct 19, 2022

Show notes

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.